Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2009

Zymeworks and XOMA Collaborate on Antibody Optimization

  • Zymeworks entered into a research agreement with XOMA to optimize an antibody. The partnership will leverage Zymeworks’ ZymeCAD™ suite of predictive protein engineering tools and XOMA’s Targeted Affinity Enhancement™ technology.

    ZymeCAD molecular simulation platform creates a modeling environment that generates novel physical and chemical insights into protein systems, according to Zymeworks.

     



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »